NRx Pharmaceuticals, a clinical-stage, biopharmaceutical company has received scientific evidence from the Israel Institute for Biological Research (IIBR) that the BriLife® vaccine may produce...
Dalriada Drug Discovery ("Dalriada") is pleased to announce a strategic collaboration with atai Life Sciences' N.V. newly launched platform company Invyxis, focused on developing...
AcelRx Pharmaceuticals, Inc a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings,announced the publication...
NeuroSense Therapeutics Ltd. a company developing treatments for neurodegenerative diseases, announced the initiation of the third stage of a collaborative biomarker study with Massachusetts...
Medline announced today the launch of its Vascular Access Health Solution, a new central line-associated bloodstream infection (CLABSI) prevention solution driven by human factors-based...
